WWOX: a candidate tumor suppressor gene involved in multiple tumor types.

PubWeight™: 2.79‹?› | Rank: Top 1%

🔗 View Article (PMC 58744)

Published in Proc Natl Acad Sci U S A on September 25, 2001

Authors

A J Paige1, K J Taylor, C Taylor, S G Hillier, S Farrington, D Scott, D J Porteous, J F Smyth, H Gabra, J E Watson

Author Affiliations

1: Imperial Cancer Research Fund (ICRF) Medical Oncology Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, United Kingdom. a.paige@icrf.icnet.uk

Articles citing this

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A (2004) 28.29

Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas. Clin Cancer Res (2009) 3.45

A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genet (2010) 3.25

Concern Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci U S A (2003) 2.52

Targeted deletion of Wwox reveals a tumor suppressor function. Proc Natl Acad Sci U S A (2007) 2.37

Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. Proc Natl Acad Sci U S A (2004) 1.91

Concern WWOX gene restoration prevents lung cancer growth in vitro and in vivo. Proc Natl Acad Sci U S A (2005) 1.84

Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma. Oncogene (2010) 1.73

The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism. J Biol Chem (2008) 1.67

Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer. J Natl Cancer Inst (2016) 1.44

Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status. Breast Cancer Res Treat (2005) 1.33

WWOX, the common chromosomal fragile site, FRA16D, cancer gene. Cytogenet Genome Res (2003) 1.28

WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome. BMC Cancer (2005) 1.22

WWOX protein expression in normal human tissues. J Mol Histol (2006) 1.22

Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma. Br J Cancer (2004) 1.22

Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas. Oncogene (2007) 1.21

Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks. J Biol Chem (2014) 1.19

Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis. Endocrinology (2008) 1.19

Generation and characterization of mice carrying a conditional allele of the Wwox tumor suppressor gene. PLoS One (2009) 1.18

Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression. Cancer Res (2010) 1.16

The tumour suppressor gene WWOX is mutated in autosomal recessive cerebellar ataxia with epilepsy and mental retardation. Brain (2013) 1.14

WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy. Genes Chromosomes Cancer (2007) 1.13

DNA instability at chromosomal fragile sites in cancer. Curr Genomics (2010) 1.11

Tumor suppressor and hepatocellular carcinoma. World J Gastroenterol (2008) 1.09

WW domain-containing oxidoreductase promotes neuronal differentiation via negative regulation of glycogen synthase kinase 3β. Cell Death Differ (2011) 1.05

Characterization of the tumor suppressor gene WWOX in primary human oral squamous cell carcinomas. Int J Cancer (2006) 1.05

WWOX, the common fragile site FRA16D gene product, regulates ATM activation and the DNA damage response. Proc Natl Acad Sci U S A (2014) 1.03

WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear. Int J Oncol (2005) 0.99

WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies. Biochim Biophys Acta (2014) 0.98

A multi-exon deletion within WWOX is associated with a 46,XY disorder of sex development. Eur J Hum Genet (2011) 0.97

Genetically engineered mouse models and human osteosarcoma. Clin Sarcoma Res (2012) 0.96

Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR. Mol Carcinog (2005) 0.95

Chromosomal aberrations related to metastasis of human solid tumors. World J Gastroenterol (2002) 0.95

Conditional inactivation of the mouse Wwox tumor suppressor gene recapitulates the null phenotype. J Cell Physiol (2013) 0.91

Molecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiforme. J Neurooncol (2010) 0.89

Establishment of an immortalised human ovarian surface epithelial cell line without chromosomal instability. Br J Cancer (2005) 0.88

Mechanism of replicative DNA polymerase delta pausing and a potential role for DNA polymerase kappa in common fragile site replication. J Mol Biol (2012) 0.88

WWOX gene is associated with HDL cholesterol and triglyceride levels. BMC Med Genet (2010) 0.88

The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX. J Hepatol (2008) 0.87

WWOX expression in colorectal cancer--a real-time quantitative RT-PCR study. Tumour Biol (2011) 0.87

WWOX induces apoptosis and inhibits proliferation of human hepatoma cell line SMMC-7721. World J Gastroenterol (2012) 0.87

Image-based assessment of growth and signaling changes in cancer cells mediated by direct cell-cell contact. PLoS One (2009) 0.87

The cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity via direct binding. BMC Cancer (2013) 0.87

Loss of WW domain-containing oxidoreductase expression in the progression and development of gastric carcinoma: clinical and histopathologic correlations. Virchows Arch (2010) 0.87

Effect of the WWOX gene on the regulation of the cell cycle and apoptosis in human ovarian cancer stem cells. Mol Med Rep (2015) 0.86

Low levels of WWOX protein immunoexpression correlate with tumour grade and a less favourable outcome in patients with urinary bladder tumours. Histopathology (2008) 0.85

Common fragile genes and digestive tract cancers. Surg Today (2006) 0.85

Requirement of evading apoptosis for HIF-1α-induced malignant progression in mouse cells. Cell Cycle (2011) 0.85

The tumor suppressor WW domain-containing oxidoreductase modulates cell metabolism. Exp Biol Med (Maywood) (2014) 0.85

WWOX: a fragile tumor suppressor. Exp Biol Med (Maywood) (2014) 0.84

The prognostic significance of WWOX expression in patients with breast cancer and its association with the basal-like phenotype. J Cancer Res Clin Oncol (2010) 0.83

Functional genetic variant in the Kozak sequence of WW domain-containing oxidoreductase (WWOX) gene is associated with oral cancer risk. Oncotarget (2016) 0.82

Epigenetic and genetic alterations affect the WWOX gene in head and neck squamous cell carcinoma. PLoS One (2015) 0.81

Oncosuppressor proteins of fragile sites are reduced in cervical cancer. Cancer Lett (2009) 0.81

Regulation of cell signaling and apoptosis by tumor suppressor WWOX. Exp Biol Med (Maywood) (2015) 0.80

WWOX and p53 Dysregulation Synergize to Drive the Development of Osteosarcoma. Cancer Res (2016) 0.79

Hypermethylation-mediated reduction of WWOX expression in intraductal papillary mucinous neoplasms of the pancreas. Br J Cancer (2009) 0.79

Functions and Epigenetic Regulation of Wwox in Bone Metastasis from Breast Carcinoma: Comparison with Primary Tumors. Int J Mol Sci (2017) 0.78

IGRhCellID: integrated genomic resources of human cell lines for identification. Nucleic Acids Res (2010) 0.78

Loss of WWOX expression in human extrahepatic cholangiocarcinoma. J Cancer Res Clin Oncol (2008) 0.76

Inactivation of BANK1 in a novel IGH-associated translocation t(4;14)(q24;q32) suggests a tumor suppressor role in B-cell lymphoma. Blood Cancer J (2014) 0.76

Expression of WW domain-containing oxidoreductase WWOX in pterygium. Mol Vis (2015) 0.75

Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk. PLoS One (2017) 0.75

Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance. Oncol Lett (2017) 0.75

PARTICLE triplexes cluster in the tumor suppressor WWOX and may extend throughout the human genome. Sci Rep (2017) 0.75

Articles cited by this

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell (1996) 15.19

WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res (2000) 4.07

Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet (2000) 2.56

Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J Biol Chem (2000) 2.20

Muir-Torre-like syndrome in Fhit-deficient mice. Proc Natl Acad Sci U S A (2000) 2.15

FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res (1997) 1.66

Role of FHIT in human cancer. J Clin Oncol (1999) 1.61

A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D. Cancer Res (2000) 1.39

Cancer-specific chromosome alterations in the constitutive fragile region FRA3B. Proc Natl Acad Sci U S A (1999) 1.33

Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region. Cancer Res (1996) 1.28

The selective isolation of novel cDNAs encoded by the regions surrounding the human interleukin 4 and 5 genes. Nucleic Acids Res (1992) 1.26

Chromosomal fragile site FRA16D and DNA instability in cancer. Cancer Res (2000) 1.17

Expression of oestrogen receptor alpha and beta in cultured human ovarian surface epithelial cells. Mol Hum Reprod (1998) 1.12

A comparison of fluorescent SSCP and denaturing HPLC for high throughput mutation scanning. Hum Mutat (2000) 1.07

Loss of heterozygosity at 3p14.2 in clear cell renal cell carcinoma is an early event and is highly localized to the FHIT gene locus. Cancer Res (1999) 1.06

Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus. Cancer Res (2000) 1.06

Deletion mapping of chromosome 16q in hepatocellular carcinoma. Br J Cancer (1999) 0.97

Articles by these authors

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 24.57

Effect of general practitioners' advice against smoking. Br Med J (1979) 24.07

Strength-duration curves for repetitive stimulation of medullated nerve. J Physiol (1934) 15.94

Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (2001) 10.96

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet (2011) 10.62

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet (2011) 9.20

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet (2011) 8.24

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet (2014) 8.04

Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet (2000) 7.16

Growth of factor-dependent hemopoietic precursor cell lines. J Exp Med (1980) 5.80

Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet (2001) 4.77

A dust-obscured massive maximum-starburst galaxy at a redshift of 6.34. Nature (2013) 4.43

Genome-wide association studies establish that human intelligence is highly heritable and polygenic. Mol Psychiatry (2011) 4.16

Alcoholism: a controlled trial of "treatment" and "advice". J Stud Alcohol (1977) 4.14

Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction (1999) 4.04

The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) (2002) 3.87

Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics (1994) 3.74

A large-scale insertional mutagenesis screen in zebrafish. Genes Dev (1999) 3.57

Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addiction (1994) 3.47

The DISC locus in psychiatric illness. Mol Psychiatry (2007) 3.46

Surveying general practitioners: does a low response rate matter? Br J Gen Pract (1997) 3.46

Findings of a national survey of the role of general practitioners in the treatment of opiate misuse: extent of contact with opiate misusers. Br Med J (Clin Res Ed) (1986) 3.33

Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism. Lancet (1982) 3.11

Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer (2004) 3.03

SUSPECTS: enabling fast and effective prioritization of positional candidates. Bioinformatics (2006) 2.96

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr (2010) 2.91

Heatstroke in well-wrapped infants. Lancet (1979) 2.81

A prognostic model for ovarian cancer. Br J Cancer (2001) 2.77

An intrinsic bond-centered electronic glass with unidirectional domains in underdoped cuprates. Science (2007) 2.76

TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres. Gut (2011) 2.75

Estimating numbers of homeless and homeless mentally ill people in north east Westminster by using capture-recapture analysis. BMJ (1994) 2.75

Self-reported overdose among injecting drug users in London: extent and nature of the problem. Addiction (1999) 2.72

The effect of cash and other financial inducements on the response rate of general practitioners in a national postal study. Br J Gen Pract (1997) 2.70

Splinkerettes--improved vectorettes for greater efficiency in PCR walking. Nucleic Acids Res (1995) 2.51

Development of an aspect of executive control: development of the abilities to remember what I said and to "do as I say, not as I do". Dev Psychobiol (1996) 2.47

Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin. N Engl J Med (1968) 2.44

Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res (1988) 2.40

Point prevalence of mental disorder in unconvicted male prisoners in England and Wales. BMJ (1996) 2.36

Deaths of drug addicts in the United Kingdom 1967-81. Br Med J (Clin Res Ed) (1985) 2.35

Bilateral human fetal striatal transplantation in Huntington's disease. Neurology (2002) 2.34

Recognition of HLA-B27 and related antigen by a monoclonal antibody. Hum Immunol (1982) 2.30

Malignant melanoma in Scotland 1979-1983. Lancet (1985) 2.30

How Cooper pairs vanish approaching the Mott insulator in Bi2Sr2CaCu2O8+delta. Nature (2008) 2.27

In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology (2007) 2.24

Methane-oxidizing microorganisms. Microbiol Rev (1981) 2.17

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med (1996) 2.17

The development of a questionnaire to measure severity of alcohol dependence. Br J Addict Alcohol Other Drugs (1979) 2.16

Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis (2008) 2.12

Cholesterol-lowering intervention program. Effect of the step I diet in community office practices. Arch Intern Med (1996) 2.11

Ectopic pregnancy: evaluation with endovaginal color flow imaging. Radiology (1992) 2.10

How should different life expectancies be valued? BMJ (1998) 2.10

Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J Clin Invest (1993) 2.10

Cystic fibrosis: terminology and diagnostic algorithms. Thorax (2005) 2.08

Blood flow in deep abdominal and pelvic vessels: ultrasonic pulsed-Doppler analysis. Radiology (1985) 2.06

Role of penile biopsy in the diagnosis of penile dermatoses. Int J STD AIDS (2010) 2.04

BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) (2007) 2.02

Human cryptosporidiosis: a possible case of hospital cross infection. Br Med J (Clin Res Ed) (1983) 2.02

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis (2007) 2.01

Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. Br J Psychiatry (2001) 2.01

Olfactory receptor gene cluster on human chromosome 17: possible duplication of an ancestral receptor repertoire. Hum Mol Genet (1994) 2.00

Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Thorax (2007) 1.93

Endomysial antibody: is it the best screening test for coeliac disease? Gut (1992) 1.93

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol (1997) 1.87

A journal core list for health administration libraries. Med Ref Serv Q (1984) 1.85

Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol Psychiatry (2001) 1.81

Isolation and characterisation of a bipotential haematopoietic cell line. Nature (1979) 1.80

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab (1996) 1.80

Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology (2008) 1.80

Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells. Transplantation (2001) 1.78

Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer (2000) 1.74

High-resolution localization of 69 potential human zinc finger protein genes: a number are clustered. Genomics (1992) 1.74

Radiation, work experience, and cause specific mortality among workers at an energy research laboratory. Br J Ind Med (1985) 1.73

Facial appearance is a cue to oestrogen levels in women. Proc Biol Sci (2006) 1.73

Early Permian bipedal reptile. Science (2000) 1.73

Grey scale echography in the diagnosis of intrahepatic disease. J Clin Ultrasound (1973) 1.71

International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) (2003) 1.71

Ultrasound and scintigraphy in the differential diagnosis of obstructive jaundice. J Clin Ultrasound (1974) 1.70

International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang (2011) 1.69

Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet (1999) 1.69

Lower extremity volumetric arterial blood flow in normal subjects. Ultrasound Med Biol (1998) 1.69

Two functional states of the CD11b A-domain: correlations with key features of two Mn2+-complexed crystal structures. J Cell Biol (1998) 1.67

A locus for bipolar affective disorder on chromosome 4p. Nat Genet (1996) 1.67

Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology (2007) 1.67

Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after x-irradiation. Int J Radiat Biol Relat Stud Phys Chem Med (1981) 1.66

Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. J Urol (1990) 1.66

Menstrual cycle, trait estrogen level, and masculinity preferences in the human voice. Horm Behav (2005) 1.65

Research for effective global tobacco control in the 21st century: report of a working group convened during the 10th World Conference on Tobacco or Health. Tob Control (1998) 1.64

Acute focal bacterial nephritis (acute lobar nephronia). Radiology (1979) 1.64

High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut (1999) 1.63

The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg (1980) 1.63

The general practitioner, the drug misuser, and the alcohol misuser: major differences in general practitioner activity, therapeutic commitment, and 'shared care' proposals. Br J Gen Pract (1997) 1.63

Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int J Radiat Biol (1999) 1.61

c-myc oncogene expression in colorectal cancer. Cancer (1987) 1.60

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Issues in the management of prisoners infected with HIV-1: the King's College Hospital HIV prison service retrospective cohort study. BMJ (2001) 1.54

Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine. Gut (1997) 1.53

Sexual mimicry regulates the attractiveness of mated Drosophila melanogaster females. Proc Natl Acad Sci U S A (1986) 1.52

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer. Br J Cancer (1996) 1.51

Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? Am J Hum Genet (1999) 1.51